Variant report
Variant | esv3324247 |
---|---|
Chromosome Location | chr5:1417052-1421450 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:14)
- CpG islands (count:183)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:14 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BACH1 | chr5:1421027-1421032 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | CTCF | chr5:1417162-1417185 | LNCaP | prostate: | n/a | n/a |
3 | CUX1 | chr5:1418482-1418682 | K562 | blood: | n/a | n/a |
4 | MAFK | chr5:1420945-1420977 | HepG2 | liver: | n/a | n/a |
5 | MYC | chr5:1418757-1418806 | HUVEC | blood vessel: | n/a | n/a |
6 | MYC | chr5:1417987-1418055 | H1-hESC | embryonic stem cell: | n/a | chr5:1418044-1418054 |
7 | NR2F2 | chr5:1416894-1417180 | K562 | blood: | n/a | n/a |
8 | NR3C1 | chr5:1416584-1417068 | A549 | lung: | n/a | n/a |
9 | NR3C1 | chr5:1416405-1417123 | A549 | lung: | n/a | n/a |
10 | NR3C1 | chr5:1416414-1417224 | A549 | lung: | n/a | n/a |
11 | NR3C1 | chr5:1416450-1417188 | A549 | lung: | n/a | n/a |
12 | RCOR1 | chr5:1419240-1419271 | K562 | blood: | n/a | n/a |
13 | RCOR1 | chr5:1419124-1419559 | K562 | blood: | n/a | n/a |
14 | ZNF263 | chr5:1418759-1418904 | HEK293-T-REx | kidney: | n/a | chr5:1418790-1418811 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:1417706-1417756 | MCF-7 | breast: | n/a |
2 | chr5:1420305-1420355 | SK-N-SH_RA | brain: | n/a |
3 | chr5:1417706-1417756 | ECC-1 | luminal epithelium: | n/a |
4 | chr5:1417003-1417053 | HIPEpiC | eye: | n/a |
5 | chr5:1417003-1417053 | NHDF-neo | bronchial: | n/a |
6 | chr5:1420305-1420355 | GM12891 | blood: | n/a |
7 | chr5:1420305-1420355 | U87 | brain: | n/a |
8 | chr5:1417003-1417053 | HRE | kidney: | n/a |
9 | chr5:1420305-1420355 | HCPEpiC | choroid plexus: | n/a |
10 | chr5:1417003-1417053 | U87 | brain: | n/a |
11 | chr5:1417706-1417756 | NH-A | brain: | n/a |
12 | chr5:1420305-1420355 | ProgFib | skin: | n/a |
13 | chr5:1420305-1420355 | ECC-1 | luminal epithelium: | n/a |
14 | chr5:1420305-1420355 | HCF | heart: | n/a |
15 | chr5:1420305-1420355 | HNPCEpiC | eye: | n/a |
16 | chr5:1420305-1420355 | IMR90 | lung: | fetal |
17 | chr5:1420305-1420355 | HPAEpiC | pulmonary alveolar: | n/a |
18 | chr5:1417003-1417053 | CMK | blood: | n/a |
19 | chr5:1420305-1420355 | K562 | blood: | n/a |
20 | chr5:1417706-1417756 | HIPEpiC | eye: | n/a |
21 | chr5:1417706-1417756 | ProgFib | skin: | n/a |
22 | chr5:1417706-1417756 | GM12878 | blood: | n/a |
23 | chr5:1417003-1417053 | HNPCEpiC | eye: | n/a |
24 | chr5:1417706-1417756 | NHDF-neo | bronchial: | n/a |
25 | chr5:1417003-1417053 | HEEpiC | esophagus: | n/a |
26 | chr5:1420305-1420355 | Hepatocyte | liver: | n/a |
27 | chr5:1417706-1417756 | HL-60 | blood: | n/a |
28 | chr5:1420305-1420355 | Caco-2 | colon: | n/a |
29 | chr5:1417003-1417053 | HPAEpiC | pulmonary alveolar: | n/a |
30 | chr5:1417706-1417756 | HNPCEpiC | eye: | n/a |
31 | chr5:1420305-1420355 | H1-hESC | embryonic stem cell: | embryo |
32 | chr5:1420305-1420355 | GM19239 | blood: | n/a |
33 | chr5:1420305-1420355 | NHBE | bronchial: | n/a |
34 | chr5:1417003-1417053 | HUVEC | blood vessel: | n/a |
35 | chr5:1417706-1417756 | HCM | heart: | n/a |
36 | chr5:1417003-1417053 | LNCaP | prostate: | n/a |
37 | chr5:1420305-1420355 | PrEC | prostate: | n/a |
38 | chr5:1420305-1420355 | SK-N-SH | brain: | n/a |
39 | chr5:1417003-1417053 | NH-A | brain: | n/a |
40 | chr5:1417706-1417756 | GM19239 | blood: | n/a |
41 | chr5:1417003-1417053 | Hela-S3 | cervix: | n/a |
42 | chr5:1417003-1417053 | BJ | skin: | n/a |
43 | chr5:1417706-1417756 | Hela-S3 | cervix: | n/a |
44 | chr5:1420305-1420355 | AG04450 | lung: | fetal |
45 | chr5:1417706-1417756 | BJ | skin: | n/a |
46 | chr5:1417003-1417053 | HRCEpiC | kidney: | n/a |
47 | chr5:1417706-1417756 | HCT-116 | colon: | n/a |
48 | chr5:1420305-1420355 | SKMC | muscle: | n/a |
49 | chr5:1417706-1417756 | SKMC | muscle: | n/a |
50 | chr5:1420305-1420355 | NB4 | blood: | n/a |
(count:4 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
SLC6A3 | TF binding region |
SLC6A3 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2652523 | chr5:1417061-1417062 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs563451980 | chr5:1417066-1417067 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs530747747 | chr5:1417093-1417094 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs536002239 | chr5:1417095-1417096 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs143574024 | chr5:1417103-1417104 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs528166157 | chr5:1417109-1417110 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs2859607 | chr5:1417116-1417117 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs541425061 | chr5:1417149-1417150 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs546389286 | chr5:1417164-1417165 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs112611577 | chr5:1417186-1417187 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs2735922 | chr5:1417187-1417188 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs535129698 | chr5:1417211-1417212 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs13161905 | chr5:1417212-1417213 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs569552884 | chr5:1417214-1417215 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs150559644 | chr5:1417217-1417218 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs558378338 | chr5:1417225-1417226 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs573516594 | chr5:1417263-1417264 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs149312034 | chr5:1417297-1417298 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs543956007 | chr5:1417314-1417315 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs37021 | chr5:1417354-1417355 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs73030164 | chr5:1417403-1417404 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
22 | rs562928505 | chr5:1417409-1417410 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
23 | rs565225730 | chr5:1417416-1417417 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
24 | rs202124739 | chr5:1417428-1417429 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
25 | rs577148903 | chr5:1417429-1417430 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
26 | rs10071624 | chr5:1417455-1417456 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
27 | rs184569642 | chr5:1417483-1417484 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
28 | rs541026286 | chr5:1417494-1417495 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
29 | rs546649357 | chr5:1417530-1417531 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
30 | rs2735921 | chr5:1417539-1417540 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561641291 | chr5:1417569-1417570 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
32 | rs529015803 | chr5:1417613-1417614 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
33 | rs559529820 | chr5:1417640-1417641 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
34 | rs550283921 | chr5:1417646-1417647 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
35 | rs2975293 | chr5:1417652-1417653 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs540126138 | chr5:1417654-1417655 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
37 | rs139478671 | chr5:1417655-1417656 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
38 | rs530167364 | chr5:1417669-1417670 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
39 | rs567023849 | chr5:1417692-1417693 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
40 | rs188319403 | chr5:1417714-1417715 | Weak transcription Bivalent Enhancer ZNF genes & repeats | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs76838441 | chr5:1417754-1417755 | Weak transcription Bivalent Enhancer ZNF genes & repeats | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs115400522 | chr5:1417766-1417767 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
43 | rs144195981 | chr5:1417790-1417791 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
44 | rs538384802 | chr5:1417795-1417796 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
45 | rs556130013 | chr5:1417806-1417807 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
46 | rs577626752 | chr5:1417845-1417846 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
47 | rs192205554 | chr5:1417865-1417866 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
48 | rs146070301 | chr5:1417888-1417889 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
49 | rs572670767 | chr5:1417917-1417918 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
50 | rs540035090 | chr5:1417944-1417945 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Lung squamous cell carcinoma | 22363434 | CNVD |
Biliary cancer | 19435499 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16608533 | CNVD |
Cervical cancer | 16585170 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Lung cancer | 17925434 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Breast cancer | 19181860 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Developmental delay | 19490664 | CNVD |
Human papillomavirus | 17975027 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Gastric cancer | 16891809 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Emphysema | 19352772 | CNVD |
Chordoma | 18071362 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Lung cancer | 21911935 | CNVD |
Cri-du chat syndrome | 21549014 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164919 | CNVD |
Oral cancer | 22144094 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Intellectual disability | 22102821 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Developmental delay | 21147756 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
Ovarian cancer | 21720365 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Melanoma | 22183965 | CNVD |
Epilepsy | 20502679 | CNVD |
Lung adenocarcinoma | 17982442 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Schizophrenia | 21346763 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:1412600-1417200 | Weak transcription | Spleen | Spleen |
2 | chr5:1415600-1418000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr5:1417200-1417400 | Enhancers | Spleen | Spleen |
4 | chr5:1417400-1417800 | Bivalent Enhancer | Right Ventricle | heart |
5 | chr5:1417400-1418200 | ZNF genes & repeats | Spleen | Spleen |
6 | chr5:1418000-1418400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr5:1418400-1419800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr5:1418600-1419200 | Active TSS | Fetal Lung | lung |
9 | chr5:1418800-1419200 | Enhancers | Fetal Kidney | kidney |
10 | chr5:1419800-1420200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr5:1420000-1421400 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
12 | chr5:1420200-1420600 | Bivalent Enhancer | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
13 | chr5:1420200-1421400 | Enhancers | Fetal Muscle Leg | muscle |
14 | chr5:1420400-1421000 | Enhancers | Fetal Thymus | thymus |
15 | chr5:1420400-1421200 | Enhancers | HSMMtube | muscle |
16 | chr5:1420400-1421400 | Enhancers | Adipose Nuclei | Adipose |
17 | chr5:1420600-1420800 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
18 | chr5:1420600-1420800 | Active TSS | Gastric | stomach |
19 | chr5:1420600-1421200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
20 | chr5:1420600-1421200 | Enhancers | Spleen | Spleen |
21 | chr5:1420600-1421400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
22 | chr5:1420800-1421000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
23 | chr5:1420800-1421000 | Bivalent Enhancer | Breast Myoepithelial Primary Cells | Breast |
24 | chr5:1420800-1421200 | Bivalent Enhancer | Placenta | Placenta |
25 | chr5:1420800-1421200 | Enhancers | Skeletal Muscle Female | skeletal muscle |
26 | chr5:1420800-1421400 | Bivalent Enhancer | Skeletal Muscle Male | skeletal muscle |
27 | chr5:1420800-1422000 | Weak transcription | Gastric | stomach |
28 | chr5:1421200-1421800 | Weak transcription | Spleen | Spleen |